Lanoxin and Keppra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lanoxin (digoxin) and Keppra (levetiracetam). Common drug interactions include overdose among females and encephalopathy among males.

The phase IV clinical study analyzes what interactions people have when they take Lanoxin and Keppra. It is created by eHealthMe based on reports of 100 people who take the same drugs from the FDA, and is updated regularly.

What is Lanoxin?

Lanoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 21,852 Lanoxin users. Check the latest studies of Lanoxin.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.



On Jul, 13, 2026

100 people who take Lanoxin and Keppra together, and have interactions are studied.

Lanoxin and Keppra drug interactions.

What are the common drug interactions of Lanoxin and Keppra, by gender? *:

female:

  1. Overdose
  2. Pain
  3. Anxiety
  4. Asthenia (weakness)
  5. Diarrhoea
  6. Dysarthria (speech disorder)
  7. Pneumonia
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Constipation
  10. Depression

male:

  1. Encephalopathy (functioning of the brain is affected by some agent or condition)
  2. Hypotension (abnormally low blood pressure)
  3. Cervical vertebral fracture
  4. Coma (state of unconsciousness lasting more than six hours)
  5. Dehydration (dryness resulting from the removal of water)
  6. Drug toxicity
  7. Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
  8. Fall
  9. Febrile neutropenia (fever with reduced white blood cells)
  10. Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)

What are the common drug interactions of Lanoxin and Keppra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  2. Encephalopathy (functioning of the brain is affected by some agent or condition)
  3. Hypotension (abnormally low blood pressure)
  4. Pyrexia (fever)
  5. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

20-29:

n/a

30-39:

  1. Abscess (pus)
  2. Activities of daily living impaired
  3. Agitation (state of anxiety or nervous excitement)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Anxiety
  6. Arrhythmia (irregular heartbeat)
  7. Arteriosclerosis (thickening and hardening of arteries)
  8. Arthropathy
  9. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  10. Back pain

40-49:

  1. Bladder disorder
  2. Cardiac failure
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Diabetes mellitus inadequate control
  6. Diabetic foot
  7. Dyspepsia (indigestion)
  8. Hyperglycaemia (high blood sugar)
  9. Loss of consciousness
  10. Partial seizures (seizures which affect only a part of the brain at onset)

50-59:

  1. Dysarthria (speech disorder)
  2. Encephalomalacia (localized softening of the brain substance, due to haemorrhage or inflammation)
  3. Encephalopathy (functioning of the brain is affected by some agent or condition)
  4. Gait disturbance
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Abscess limb (limb infection)
  7. Cardiovascular disorder (heart diseases)
  8. Cellulitis (infection under the skin)
  9. Death
  10. Perirectal abscess

60+:

  1. Fatigue (feeling of tiredness)
  2. Cardioactive drug level increased
  3. Dizziness
  4. Dysphagia (a condition in which swallowing is difficult or painful)
  5. Nausea (feeling of having an urge to vomit)
  6. Anxiety
  7. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  8. Constipation
  9. Depression
  10. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)

What are the existing conditions these people have? *

  1. High Blood Pressure: 18 people, 18.00%
  2. Diabetes: 16 people, 16.00%
  3. Post-Traumatic Epilepsy: 14 people, 14.00%
  4. Gastritis (inflammation of stomach): 14 people, 14.00%
  5. Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 14 people, 14.00%
  6. Cardiac Disorder: 14 people, 14.00%
  7. Cardiomyopathy (weakening of the heart muscle): 12 people, 12.00%
  8. Pain: 11 people, 11.00%
  9. Adjustment Disorder With Depressed Mood: 10 people, 10.00%
  10. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 7 people, 7.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lanoxin and Keppra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lanoxin and Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lanoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lanoxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Keppra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on digoxin and levetiracetam (the active ingredients of Lanoxin and Keppra, respectively), and Lanoxin and Keppra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: